Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis causes cerebral dysfunction in the short and long term and induces disruption of the blood–brain barrier (BBB), neuroinflammation, hypoperfusion, and accumulation of amyloid β (Aβ) and tau protein in the brain. White matter changes and brain atrophy can be detected using brain imaging, but unfortunately, there is no specific treatment that directly addresses the underlying mechanisms of cognitive impairments in sepsis. Here, we review the underlying mechanisms of sepsis-associated brain injury, with a focus on BBB dysfunction and Aβ and tau protein accumulation in the brain. We also describe the neurological manifestations and imaging findings of sepsis-associated brain injury, and finally, we propose potential therapeutic strategies for acute and long-term cognitive impairments associated with sepsis. In the acute phase of sepsis, we suggest using antibiotics (such as rifampicin), targeting proinflammatory cytokines, and preventing ischemic injuries and hypoperfusion. In the late phase of sepsis, we suggest targeting neuroinflammation, BBB dysfunction, Aβ and tau protein phosphorylation, glycogen synthase kinase-3 beta (GSK3β), and the receptor for advanced glycation end products (RAGE). These proposed strategies are meant to bring new mechanism-based directions for future basic and clinical research aimed at preventing or ameliorating acute and long-term cognitive impairments in patients with sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · cited 1×
“, aducanumab) can slow disease progression in patients with AD [58, 147].”
BackgroundIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Long-term cognitive impairment after critical illness
Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301372 · Cited by 2,842
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0036-4 · Cited by 1,406 · cited 1×
“Targeting IL-1 abolished both CRS and neurotoxicity, whereas targeting IL-6 has failed to suppress delayed lethal neurotoxicity in humanized mice models [123].”
BackgroundSystemic inflammation and microglial activation: systematic review of animal experiments
Hoogland, I. C. M., Houbolt, C., van Westerloo, D. J., van Gool, W. A., & van de Beek, D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0332-6 · Cited by 957 · cited 2×
“Microglia is the main inflammatory cell that gets activated in sepsis [26] in animals [27] and humans [28].”
BackgroundShakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Cytokine-induced sickness behavior
Kelley, K. W., Bluthé, R.-M., Dantzer, R., Zhou, J.-H., Shen, W.-H., Johnson, R. W., & Broussard, S. R. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00077-6 · Cited by 716
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
Gutierrez, E. G., Banks, W. A., & Kastin, A. J. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90027-v · Cited by 577 · cited 1×
“TNF receptor (TNFR) elevates cytokine levels in the brain [24, 25].”
BackgroundEricsson, A., Liu, C., Hart, R. P., & Sawchenko, P. E. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903610410 · Cited by 471
The endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457 · cited 1×
“Data from animal models show that Aβ plaques and p-tau also accumulate acutely after experimental sepsis [59, 61].”
BackgroundLue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439 · cited 2×
“Targeting RAGE RAGE is upregulated in microglia and neurons in the brains of patients with AD [85], and it has been identified as an important link between inflammation, amyloidogenesis, and apoptosis during AD progression [78, 79].”
BackgroundSharshar, T., Gray, F., de la Grandmaison, G. L., Hopklnson, N. S., Ross, E., Dorandeu, A., Orlikowski, D., Raphael, J.-C., Gajdos, P., & Annane, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14899-4 · Cited by 341 · cited 1×
“found that apoptotic neurons were found in the amygdala, as well as in the hypothalamus and medulla [89, 116].”
BackgroundFang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335 · cited 1×
“showed that transgenic mice expressing human mutant APP in neurons and RAGE in microglia displayed enhanced IL-1β and TNF-α production, increased infiltration of microglia and astrocytes, accumulation of Aβ, reduced acetylcholine esterase activity, and accelerated deterioration of spatial learning/ memory [87].”
BackgroundPotentially modifiable factors contributing to sepsis-associated encephalopathy
Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., Mariotte, E., Argaud, L., Barbier, F., Goldgran-Toledano, D., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4807-z · Cited by 323 · cited 1×
“reported that 53% of 2513 patients with sepsis admitted to the ICU had SAE, which was associated with a higher mortality rate, higher use of ICU resources, and a longer hospital stay [96].”
BackgroundCognitive decline after sepsis.
Annane, D., & Sharshar, T. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70246-2 · Cited by 290
Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., & Shaikh, M. F. (2020) · Cells · doi:10.3390/cells9020383 · Cited by 257
Microglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Cerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191
Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies
Catarina, A. V., Branchini, G., Bettoni, L., De Oliveira, J. R., & Nunes, F. B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02303-2 · Cited by 155
Moraes, C. A., Santos, G., Spohr, T. C. L. D. S. E., D’Avila, J. C., Lima, F. R. S., Benjamim, C. F., Bozza, F. A., & Gomes, F. C. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8868-5 · Cited by 145 · cited 1×
“Once microglia are activated, they most likely induce brain damage during sepsis [29, 31].”
BackgroundNadeau, S., & Rivest, S. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199901000-00008 · Cited by 142
Lv, S., Song, H.-L., Zhou, Y., Li, L.-X., Cui, W., Wang, W., & Liu, P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02211.x · Cited by 120
Gasparotto, J., Girardi, C. S., Somensi, N., Ribeiro, C. T., Moreira, J. C. F., Michels, M., Sonai, B., Rocha, M., Steckert, A. V., Barichello, T., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786756 · Cited by 120 · cited 2×
“In animal models of sepsis, the levels of RAGE and p-tau are increased in the rat brain [63], and the injection of RAGE antibodies into the hippocampus reduces Aβ and p-tau accumulation [60].”
BackgroundImaging in sepsis-associated encephalopathy—insights and opportunities
Stubbs, D. J., Yamamoto, A. K., & Menon, D. K. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.177 · Cited by 118
Fang, F., Yu, Q., Arancio, O., Chen, D., Gore, S. S., Yan, S. S., & Yan, S. F. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy017 · Cited by 103
Ye, B., Tao, T., Zhao, A., Wen, L., He, X., Liu, Y., Fu, Q., Mi, W., & Lou, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/8461725 · Cited by 83 · cited 1×
“In the CLP animal model, neutralizing anti-IL-17A or anti-IL-17R antibodies mitigated neuroinflammation and microglia activation, and alleviated cognitive dysfunction [136].”
BackgroundRegulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, E. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00018 · Cited by 82
Ehler, J., Barrett, L. K., Taylor, V., Groves, M., Scaravilli, F., Wittstock, M., Kolbaske, S., Grossmann, A., Henschel, J., Gloger, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1850-7 · Cited by 80 · cited 3×
“In patients with sepsis and SAE, vasogenic edema and WM hyperintensities on MRI are found frequently, indicating BBB disruption [39, 40].”
BackgroundAlteration of sphingolipid metabolism as a putative mechanism underlying LPS‐induced BBB disruption
Vutukuri, R., Brunkhorst, R., Kestner, R., Hansen, L., Bouzas, N. F., Pfeilschifter, J., Devraj, K., & Pfeilschifter, W. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14236 · Cited by 57 · cited 1×
“Serum-S1P levels are dramatically decreased and inversely associated with disease severity in patients with sepsis [44] and in LPS-induced SAE in mice [142].”
BackgroundWu, H., Deng, R., Chen, X., Wong, W. C., Chen, H., Gao, L., Nie, Y., Wu, W., & Shen, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3734-15.2016 · Cited by 49 · cited 1×
“found that caveolin-1 facilitates T-cell trafficking into the CNS via ICAM-1-mediated signaling [46].”
Background
Cited by
Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1090288 · Cited by 46
Zhou, Z., Yang, Y., Wei, Y., & Xie, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04115-x · Cited by 30
Chen, K., Linares, I. M., Trempel, M. A., Feidler, A. M., De Silva, D., Farajollahi, S., Jones, J., Kuebel, J., Kasap, P., Engelhardt, B., et al. (2025) · Advanced Science · doi:10.1002/advs.202508271 · Cited by 9
Metadata
- Authors
- Sekino, N., Selim, M., & Shehadah, A.
- Venue
- Journal of Neuroinflammation
- Published
- 2022-04-29
- Volume
- 19
- Issue
- 1
- Pages
- 101-101
- ISSN
- 1742-2094 (ISSN-L)
- OpenAlex
- W4225115620
- Cited by
- 138
- References
- 37
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.